Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Lancet Neurol. 2017 Mar 20;16(5):351–359. doi: 10.1016/S1474-4422(17)30056-X

Table 3.

DTBZ and DASB binding per group in Study 2

Group DASB BP–Cortex (mean, sd) DASB BP–Striatum (mean, sd) DASB BP–Brainstem (mean, sd) DASB BP–Hypothalamus (mean, sd) DTBZ–putamen (mean, sd)*
HC 0·43 (0·10) 1·61 (0·21) 2·14 (0·51) 1·90 (0·40) -
LRRK2-U 0·55 (0·10) 1·70 (0·23) 2·36 (0·43) 2·55 (0·49) 1·04 (0·28)
LRRK2-PD 0·38 (0·09) 1·41 (0·14) 1·86 (0·26) 1·87 (0·35) 0·30 (0·11)
sPD 0·41 (0·15) 1·35 (0·30) 2·07 (0·33) 2·01 (0·33) 0·25 (0·11)

HC= healthy control; LRRK2-U= unaffected mutation carrier; LRRK2-PD= affected mutation carrier; sPD = sporadic PD

*

DTBZ data are expressed as a left/right average normalized to age-matched healthy control values